Value proposition

Helping asthma and COPD patients live longer, healthier lives.

Medicare Advantage Plans & ACOs have seen their costs grow in COPD by 53% since 2010, because of high admission and readmission rates (22%). More expensive inhalers are not the only solution to curb this trend.

Pulmonary Rehabilitation (PR) is a comprehensive intervention including endurance training, behaviour change and patient education which is proven to significantly improve COPD outcomes.

Pulmonary Rehab has been around for decades and recommended by global and national guidelines, but less than 2% of COPD patients get access because there is one PR center for every 43,000 COPD patients in the US.

BreatheSuite is a fully virtual Pulmonary Rehabilitation program designed to reduce COPD readmissions and medical expenses. BreatheSuite’s fully virtual program is built on clinically validated protocols, proven to save $5,700 per enrolled patient annually.

Medical Device, Medication Adherence, Asthma, and COPD